BUY Biocon Ltd — Vikas Salunkhe, Nirmal Bang Securities
byVikas Salunkhe, Nirmal Bang SecuritiesHorizon: NA (inferred Swing (≤2wk))18 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjector
NewsEt-Markets·18 Aug · today
5 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·17 Aug · 2d ago
Biocon Shares Surge Nearly 3% After Q1 Profit Jumps 350%
NewsNdtv-Profit·6 Aug · 2w ago
Biocon Q1 Results: Profit Spikes 350%, Revenue Exceeds Rs 4,300 Crore
NewsNdtv-Profit·5 Aug · 2w ago
Biocon Q1 Results: Net profit jumps over four-fold as biopharma business drives growth
NewsCnbc-Tv18·5 Aug · 2w ago
Buy, Sell Or Hold: Mazagon Dock, HAL, Biocon, Suzlon And Tata Motors PV — Ask Profit
NewsNdtv-Profit·18 Aug · today
From profit surges to margin worries: The big takeaways from Wednesday's earnings
NewsCnbc-Tv18·5 Aug · 2w ago
Biocon Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·5 Aug · 2w ago
Q1 Results Today Highlights: Godrej Agrovet posts mixed Q1; Whirlpool PAT falls 34%, Berger Paints, Biocon, Shilpa Medicare, Aster DM, Navin Fluorine report profit growth
NewsHbl·5 Aug · 2w ago
Market Pulse: Key triggers to watch before the Aug 5 trading session
NewsCnbc-Tv18·4 Aug · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Biocon
- BUY — Kunal Bothra22 Oct 2026 · ~2 weeks · target ₹345 · SL hit
- SELL — Rajesh Satpute9 Oct 2026 · ~3 months · target ₹335 · Active
- BUY — Axis Securities19 Sept 2026 · ~3 months · target ₹424 · Active
- BUY — Prakash Gaba17 Sept 2026 · ~2 weeks · target ₹390 · Target hit
- BUY — Vikas Salunkhe, Nirmal Bang Securities27 Aug 2026 · ~2 weeks · target ₹440 · SL hit
More from Vikas Salunkhe, Nirmal Bang Securities
- BUY Mahindra & Mahindra15 Oct 2026 · ~2 weeks · target ₹3,000 · Active
- BUY Kotak Mahindra Bank15 Oct 2026 · ~2 weeks · target ₹472 · SL hit
- BUY DLF15 Oct 2026 · Same day · target ₹680 · Expired
- BUY Kotak Mahindra Bank15 Oct 2026 · ~2 weeks · target ₹462 · SL hit
- BUY DLF15 Oct 2026 · Same day · target ₹684 · Expired

